Announcements Trials
Browse Landscape

Phase

Phase NA 6Phase EARLY_PHASE1 2Phase 2 2

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2

Conditions

Multiple Myeloma 26Breast Neoplasms 21Colorectal Neoplasms 17Neoplasms 15Lymphoma, B-Cell 15Prostatic Neoplasms 14Stomach Neoplasms 12Carcinoma, Hepatocellular 12Recurrence 11Lung Neoplasms 11Burkitt Lymphoma 11Solid Tumor 10Pancreatic Neoplasms 10Leukemia, Myeloid, Acute 10Carcinoma, Non-Small-Cell Lung 10Uterine Cervical Neoplasms 9Lymphoma, Non-Hodgkin 9Glioblastoma 9Leukemia 8Ovarian Neoplasms 7Sarcoma 6Polycystic Ovary Syndrome 6Glioma 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma 5Hematologic Neoplasms 5Head and Neck Neoplasms 5Neuroendocrine Tumors 4Lymphoma, T-Cell, Peripheral 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Unknown × Fasting × Clear all
NCT04617704 2021-09-22

BCMA and CD19 Targeted Fast Dual CART for Chromosomal Abnomalities High-risk BCMA+ Multiple Myeloma

Shanghai Changzheng Hospital

Phase EARLY_PHASE1 Unknown
15 enrolled
Plasma cell

Fasting, Multiple Myeloma

NCT04236011 2021-06-15

BCMA and CD19 Targeted Fast Dual CAR-T for BCMA+ Refractory/Relapsed Multiple Myeloma

Shanghai Changzheng Hospital

Phase EARLY_PHASE1 Unknown
15 enrolled
Plasma cell

Fasting, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡